NACSELD Acute-on-Chronic Liver Failure
NACSELD Acute-on-Chronic Liver Failure - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the NACSELD Acute-on-Chronic Liver Failure → Runs in your browser. No signup, no tracking.
What this is
NACSELD Acute-on-Chronic Liver Failure is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. NACSELD Acute-on-Chronic Liver Failure - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
O’Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67(6):2367-2374. Read the source ↗
Worked example: NACSELD-ACLF: 2 organ failure(s) — ACLF (>= 2), 30-day survival ~59%.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.